Template:Enalapril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
* [[Enalapril maleate and Hydrochlorothiazide tablet]] | * [[Enalapril maleate and Hydrochlorothiazide tablet]] | ||
===''[[Enalapril and Felodipine]]''=== | |||
* [[Enalapril maleate and Felodipine]]''=== | |||
==Overview== | ==Overview== | ||
Revision as of 20:54, 2 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]
Enalapril
Enalapril and Hydrochlorothiazide
Enalapril and Felodipine
Overview
Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.